Sector: Health Care
Director information for ALLOGENE THERAPEUTICS INC
Board as disclosed in the proxy statement filed April 30, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Arie Belldegrun | M.D. (EC) | 76 | [] | [] | 2026 |
| David Chang, M.D., Ph.D. | 66 | [] | [] | 2026 | |
| Deborah Messemer | 68 | [] | ["C","Compensation"] | 2026 | |
| Elizabeth Barrett | 63 | [] | ["Audit","Compensation"] | 2026 | |
| Franz Humer, Ph.D. | Ph.D. (LID) | 79 | [] | ["C"] | 2026 |
| John DeYoung | 63 | [] | ["Audit","Compensation"] | 2026 | |
| Joshua Kazam | 49 | [] | ["Compensation"] | 2026 | |
| Owen Witte, M.D. | 76 | [] | ["C"] | 2026 | |
| Stephen Mayo, Ph.D. | 64 | [] | ["Audit","Research and Development"] | 2026 | |
| Todd Sisitsky | 54 | [] | ["Compensation"] | 2026 | |
| Vicki Sato, Ph.D. | 77 | [] | ["Research and Development","Compensation"] | 2026 |
